

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of muscle hypertrophy (GO:0014741) | 9.62704147 |
| 2 | skeletal muscle tissue regeneration (GO:0043403) | 8.95610015 |
| 3 | negative regulation of skeletal muscle tissue development (GO:0048642) | 8.32273765 |
| 4 | muscle filament sliding (GO:0030049) | 8.17407856 |
| 5 | actin-myosin filament sliding (GO:0033275) | 8.17407856 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 7.67247877 |
| 7 | response to muscle activity (GO:0014850) | 7.11637010 |
| 8 | actin-mediated cell contraction (GO:0070252) | 6.67053887 |
| 9 | cellular response to dexamethasone stimulus (GO:0071549) | 5.96684304 |
| 10 | response to activity (GO:0014823) | 5.59752071 |
| 11 | response to dexamethasone (GO:0071548) | 5.51130631 |
| 12 | actin filament-based movement (GO:0030048) | 5.01576855 |
| 13 | striated muscle adaptation (GO:0014888) | 4.94664696 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.52828644 |
| 15 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.44314276 |
| 16 | regulation of muscle hypertrophy (GO:0014743) | 4.36779093 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.31441829 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.31441829 |
| 19 | muscle adaptation (GO:0043500) | 4.23325133 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.22357663 |
| 21 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.17357118 |
| 22 | dosage compensation (GO:0007549) | 3.78373469 |
| 23 | tissue regeneration (GO:0042246) | 3.76371156 |
| 24 | skeletal muscle contraction (GO:0003009) | 3.76176596 |
| 25 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.56645119 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.39033323 |
| 27 | response to testosterone (GO:0033574) | 3.36096274 |
| 28 | protein K6-linked ubiquitination (GO:0085020) | 3.27901075 |
| 29 | cellular response to glucocorticoid stimulus (GO:0071385) | 3.27225479 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 3.25517393 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.25065153 |
| 32 | regulation of relaxation of muscle (GO:1901077) | 3.19958934 |
| 33 | germinal center formation (GO:0002467) | 3.15840485 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.12779313 |
| 35 | cellular response to type I interferon (GO:0071357) | 3.12074084 |
| 36 | type I interferon signaling pathway (GO:0060337) | 3.12074084 |
| 37 | cytidine deamination (GO:0009972) | 3.09677411 |
| 38 | cytidine metabolic process (GO:0046087) | 3.09677411 |
| 39 | cytidine catabolic process (GO:0006216) | 3.09677411 |
| 40 | cellular response to corticosteroid stimulus (GO:0071384) | 3.08460812 |
| 41 | negative regulation of histone acetylation (GO:0035067) | 3.07144011 |
| 42 | response to type I interferon (GO:0034340) | 3.06102681 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05310456 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.04709015 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01639605 |
| 46 | response to electrical stimulus (GO:0051602) | 2.99570466 |
| 47 | cellular response to ketone (GO:1901655) | 2.99130453 |
| 48 | myotube cell development (GO:0014904) | 2.99050459 |
| 49 | muscle organ development (GO:0007517) | 2.98700479 |
| 50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.97646651 |
| 51 | heparin metabolic process (GO:0030202) | 2.96274117 |
| 52 | heparin biosynthetic process (GO:0030210) | 2.96274117 |
| 53 | negative regulation of striated muscle tissue development (GO:0045843) | 2.93004055 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 2.91669144 |
| 55 | muscle structure development (GO:0061061) | 2.90424031 |
| 56 | regulation of germinal center formation (GO:0002634) | 2.89677136 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 2.85731649 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83008436 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 2.82767202 |
| 60 | negative regulation of muscle tissue development (GO:1901862) | 2.81031531 |
| 61 | negative regulation of muscle organ development (GO:0048635) | 2.79354933 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78092292 |
| 63 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77899894 |
| 64 | positive regulation by symbiont of host defense response (GO:0052509) | 2.76850275 |
| 65 | modulation by symbiont of host defense response (GO:0052031) | 2.76850275 |
| 66 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76850275 |
| 67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.76850275 |
| 68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.76850275 |
| 69 | modulation by symbiont of host immune response (GO:0052553) | 2.76850275 |
| 70 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.74554503 |
| 71 | cellular extravasation (GO:0045123) | 2.74470077 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.69904250 |
| 73 | viral genome replication (GO:0019079) | 2.69505448 |
| 74 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.69453032 |
| 75 | negative regulation of organelle assembly (GO:1902116) | 2.68797454 |
| 76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.63068476 |
| 77 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.60910044 |
| 78 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.59735732 |
| 79 | muscle system process (GO:0003012) | 2.59355167 |
| 80 | regulation of DNA methylation (GO:0044030) | 2.56927901 |
| 81 | regulation of regulatory T cell differentiation (GO:0045589) | 2.50251060 |
| 82 | negative regulation of interleukin-12 production (GO:0032695) | 2.50238930 |
| 83 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.46554652 |
| 84 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.46406062 |
| 85 | response to interferon-beta (GO:0035456) | 2.43903310 |
| 86 | neutrophil activation (GO:0042119) | 2.43828853 |
| 87 | regulation of B cell differentiation (GO:0045577) | 2.41996954 |
| 88 | muscle contraction (GO:0006936) | 2.41232796 |
| 89 | monocyte differentiation (GO:0030224) | 2.39760986 |
| 90 | skeletal muscle fiber development (GO:0048741) | 2.37761466 |
| 91 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.36783850 |
| 92 | T cell migration (GO:0072678) | 2.36090325 |
| 93 | regulation of T cell tolerance induction (GO:0002664) | 2.35827043 |
| 94 | cellular response to interferon-gamma (GO:0071346) | 2.35073327 |
| 95 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.34483026 |
| 96 | regulation of myeloid cell apoptotic process (GO:0033032) | 2.33847270 |
| 97 | response to gravity (GO:0009629) | 12.6267843 |
| 98 | skeletal muscle adaptation (GO:0043501) | 11.9705044 |
| 99 | striated muscle atrophy (GO:0014891) | 11.7186144 |
| 100 | muscle atrophy (GO:0014889) | 10.3053461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.97986433 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 6.05392770 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.96096195 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.35536732 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.89288512 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.61819578 |
| 7 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.38057162 |
| 8 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.16599559 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.05801866 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.90201682 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86684243 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.75427911 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54743168 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.48560922 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39923103 |
| 16 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39405183 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.22102585 |
| 18 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.19776210 |
| 19 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.19011997 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17758372 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.15466760 |
| 22 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14971823 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.14121861 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.08721749 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.02191444 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96879551 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83876256 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81536772 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75489614 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.74994183 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70769390 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.63995408 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61758168 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.59955412 |
| 35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55230560 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53319634 |
| 37 | * MAF_26560356_Chip-Seq_TH1_Human | 1.44053721 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43431415 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39949715 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36813001 |
| 41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.34043723 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33181748 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.32038079 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.31449856 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25077035 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23439300 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22709176 |
| 48 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21017799 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19579764 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18666735 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16609088 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15899054 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13222558 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10533642 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08993977 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08396013 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06869977 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06795739 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05616651 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04882451 |
| 61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.03490647 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99868414 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99679989 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98788499 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95600153 |
| 66 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.94720921 |
| 67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94478618 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.93055121 |
| 69 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92690896 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90394544 |
| 71 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90324733 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89704442 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88985272 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88556537 |
| 75 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88308631 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87853591 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87752238 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87725868 |
| 79 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82380850 |
| 80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82082230 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.78558155 |
| 82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.76455081 |
| 83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75499802 |
| 84 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.74461645 |
| 85 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.73756955 |
| 86 | CJUN_26792858_Chip-Seq_BT549_Human | 0.73289649 |
| 87 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73229760 |
| 88 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.72508689 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.71922876 |
| 90 | GATA3_26560356_Chip-Seq_TH1_Human | 0.71828229 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71248323 |
| 92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70887018 |
| 93 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.69785718 |
| 94 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.69729959 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.69405494 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68121717 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.67018676 |
| 98 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.66926037 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66703784 |
| 100 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.66454680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000747_muscle_weakness | 4.72057239 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 3.84366596 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.67353213 |
| 4 | MP0004036_abnormal_muscle_relaxation | 3.55167578 |
| 5 | MP0002089_abnormal_postnatal_growth/wei | 3.51487693 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.20826697 |
| 7 | MP0000749_muscle_degeneration | 3.19205155 |
| 8 | MP0002269_muscular_atrophy | 3.18340014 |
| 9 | MP0005083_abnormal_biliary_tract | 3.08233988 |
| 10 | MP0003724_increased_susceptibility_to | 2.94292868 |
| 11 | MP0000759_abnormal_skeletal_muscle | 2.79789721 |
| 12 | MP0002108_abnormal_muscle_morphology | 2.25132420 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.24856962 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.18105546 |
| 15 | MP0003303_peritoneal_inflammation | 2.15958319 |
| 16 | MP0002106_abnormal_muscle_physiology | 2.10648693 |
| 17 | MP0005387_immune_system_phenotype | 2.06143611 |
| 18 | MP0001790_abnormal_immune_system | 2.06143611 |
| 19 | MP0009785_altered_susceptibility_to | 2.05753065 |
| 20 | MP0005671_abnormal_response_to | 2.05096914 |
| 21 | MP0002723_abnormal_immune_serum | 1.99256550 |
| 22 | MP0005620_abnormal_muscle_contractility | 1.97665655 |
| 23 | MP0003959_abnormal_lean_body | 1.95213143 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.92572283 |
| 25 | MP0000685_abnormal_immune_system | 1.92454533 |
| 26 | MP0002419_abnormal_innate_immunity | 1.91337817 |
| 27 | MP0001800_abnormal_humoral_immune | 1.90046624 |
| 28 | MP0003436_decreased_susceptibility_to | 1.81816493 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.76464945 |
| 30 | MP0005025_abnormal_response_to | 1.67851344 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.67761520 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.66969522 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.65192001 |
| 34 | MP0004947_skin_inflammation | 1.64388801 |
| 35 | MP0001819_abnormal_immune_cell | 1.64088883 |
| 36 | MP0003045_fibrosis | 1.58965213 |
| 37 | MP0005369_muscle_phenotype | 1.58945252 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.53670743 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.46627944 |
| 40 | MP0000733_abnormal_muscle_development | 1.45473944 |
| 41 | MP0006082_CNS_inflammation | 1.40252102 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.39195481 |
| 43 | MP0000750_abnormal_muscle_regeneration | 1.35910606 |
| 44 | MP0000751_myopathy | 1.32090428 |
| 45 | MP0008469_abnormal_protein_level | 1.31961655 |
| 46 | MP0002332_abnormal_exercise_endurance | 1.28322028 |
| 47 | MP0005166_decreased_susceptibility_to | 1.25751575 |
| 48 | MP0001243_abnormal_dermal_layer | 1.25576082 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.25441038 |
| 50 | MP0002896_abnormal_bone_mineralization | 1.22851833 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.22493538 |
| 52 | MP0002398_abnormal_bone_marrow | 1.21239803 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.18359729 |
| 54 | MP0000716_abnormal_immune_system | 1.16374285 |
| 55 | MP0003828_pulmonary_edema | 1.10355793 |
| 56 | MP0006054_spinal_hemorrhage | 1.08975641 |
| 57 | MP0004484_altered_response_of | 1.05767857 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.05295425 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.04429670 |
| 60 | MP0010307_abnormal_tumor_latency | 1.03473854 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.02999388 |
| 62 | MP0000427_abnormal_hair_cycle | 1.02799738 |
| 63 | MP0002722_abnormal_immune_system | 1.02323154 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.02122696 |
| 65 | MP0000569_abnormal_digit_pigmentation | 0.99885108 |
| 66 | MP0000689_abnormal_spleen_morphology | 0.99647518 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.99277574 |
| 68 | MP0003795_abnormal_bone_structure | 0.98191367 |
| 69 | MP0009764_decreased_sensitivity_to | 0.96550007 |
| 70 | MP0004130_abnormal_muscle_cell | 0.95629761 |
| 71 | MP0003300_gastrointestinal_ulcer | 0.94843983 |
| 72 | MP0002405_respiratory_system_inflammati | 0.90513968 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.89129126 |
| 74 | MP0003075_altered_response_to | 0.87703822 |
| 75 | MP0002095_abnormal_skin_pigmentation | 0.87663741 |
| 76 | MP0005334_abnormal_fat_pad | 0.86977429 |
| 77 | MP0003646_muscle_fatigue | 0.86925160 |
| 78 | MP0001542_abnormal_bone_strength | 0.86539320 |
| 79 | MP0002429_abnormal_blood_cell | 0.83305381 |
| 80 | MP0002396_abnormal_hematopoietic_system | 0.83033432 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.82907252 |
| 82 | MP0000343_altered_response_to | 0.81048169 |
| 83 | MP0003786_premature_aging | 0.81019928 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.80227513 |
| 85 | MP0009333_abnormal_splenocyte_physiolog | 0.78142997 |
| 86 | MP0002971_abnormal_brown_adipose | 0.77441508 |
| 87 | MP0003091_abnormal_cell_migration | 0.75200283 |
| 88 | MP0004510_myositis | 0.74173762 |
| 89 | MP0003252_abnormal_bile_duct | 0.72480982 |
| 90 | MP0002132_abnormal_respiratory_system | 0.72024225 |
| 91 | MP0005275_abnormal_skin_tensile | 0.68730558 |
| 92 | MP0004084_abnormal_cardiac_muscle | 0.66809644 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.64586301 |
| 94 | MP0002006_tumorigenesis | 0.61855342 |
| 95 | MP0001851_eye_inflammation | 0.61156262 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.58941031 |
| 97 | MP0005390_skeleton_phenotype | 0.58583797 |
| 98 | MP0003866_abnormal_defecation | 0.57726929 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.57576114 |
| 100 | MP0001545_abnormal_hematopoietic_system | 0.57576114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 9.41508807 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.39387265 |
| 3 | Distal arthrogryposis (HP:0005684) | 7.12915719 |
| 4 | Mask-like facies (HP:0000298) | 7.02106307 |
| 5 | Nemaline bodies (HP:0003798) | 6.93442139 |
| 6 | Round ear (HP:0100830) | 6.46435785 |
| 7 | Ulnar deviation of the wrist (HP:0003049) | 5.80037983 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 5.50081142 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.44413842 |
| 10 | Absent phalangeal crease (HP:0006109) | 5.43372568 |
| 11 | Hyperkalemia (HP:0002153) | 5.20385029 |
| 12 | Periorbital edema (HP:0100539) | 4.87754941 |
| 13 | Calcaneovalgus deformity (HP:0001848) | 4.87290702 |
| 14 | Facial edema (HP:0000282) | 4.71766472 |
| 15 | Abnormal finger flexion creases (HP:0006143) | 4.66713009 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 4.42959274 |
| 17 | Deformed tarsal bones (HP:0008119) | 4.36609690 |
| 18 | Myopathic facies (HP:0002058) | 3.78601273 |
| 19 | Myoglobinuria (HP:0002913) | 3.75466989 |
| 20 | Increased connective tissue (HP:0009025) | 3.60325320 |
| 21 | Exercise-induced muscle cramps (HP:0003710) | 3.40488903 |
| 22 | Difficulty running (HP:0009046) | 3.32415308 |
| 23 | Abnormality of the peritoneum (HP:0002585) | 3.28252137 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 3.23275509 |
| 25 | Rhabdomyolysis (HP:0003201) | 3.06597301 |
| 26 | Recurrent abscess formation (HP:0002722) | 3.01427684 |
| 27 | Abnormality of potassium homeostasis (HP:0011042) | 2.95017754 |
| 28 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.84537069 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.82926198 |
| 30 | Neoplasm of the heart (HP:0100544) | 2.81831527 |
| 31 | Nonprogressive disorder (HP:0003680) | 2.62723078 |
| 32 | Myositis (HP:0100614) | 2.59146444 |
| 33 | Metatarsus adductus (HP:0001840) | 2.54007545 |
| 34 | Eczematoid dermatitis (HP:0000976) | 2.51946511 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.44433634 |
| 36 | Abnormality of the calcaneus (HP:0008364) | 2.43197771 |
| 37 | Increased variability in muscle fiber diameter (HP:0003557) | 2.38905709 |
| 38 | Myotonia (HP:0002486) | 2.35656951 |
| 39 | Oligomenorrhea (HP:0000876) | 2.31158257 |
| 40 | Cellulitis (HP:0100658) | 2.28963541 |
| 41 | Orchitis (HP:0100796) | 2.27330193 |
| 42 | Muscle stiffness (HP:0003552) | 2.26104053 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.26065814 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.24088518 |
| 45 | Optic neuritis (HP:0100653) | 2.23808138 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.23808138 |
| 47 | Toxemia of pregnancy (HP:0100603) | 2.23272871 |
| 48 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.22972747 |
| 49 | Meningitis (HP:0001287) | 2.20649939 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.16122462 |
| 51 | Malignant hyperthermia (HP:0002047) | 2.12529497 |
| 52 | Stomatitis (HP:0010280) | 2.11373253 |
| 53 | Chest pain (HP:0100749) | 2.06291544 |
| 54 | Decreased circulating renin level (HP:0003351) | 2.05864522 |
| 55 | Microglossia (HP:0000171) | 2.05467572 |
| 56 | Recurrent fungal infections (HP:0002841) | 2.03520472 |
| 57 | Recurrent skin infections (HP:0001581) | 2.00652899 |
| 58 | Hyperphosphatemia (HP:0002905) | 2.00549087 |
| 59 | T lymphocytopenia (HP:0005403) | 1.98939420 |
| 60 | Abnormality of chloride homeostasis (HP:0011422) | 1.93239276 |
| 61 | Down-sloping shoulders (HP:0200021) | 1.93218654 |
| 62 | Abnormality of the prostate (HP:0008775) | 1.90840145 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 1.90293674 |
| 64 | Paralysis (HP:0003470) | 1.89910097 |
| 65 | Vasculitis (HP:0002633) | 1.89278587 |
| 66 | Abnormality of T cell number (HP:0011839) | 1.87636314 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 1.87541840 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.85812615 |
| 69 | Recurrent viral infections (HP:0004429) | 1.84948166 |
| 70 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81486022 |
| 71 | Pulmonary embolism (HP:0002204) | 1.80558470 |
| 72 | Bell-shaped thorax (HP:0001591) | 1.77828741 |
| 73 | IgM deficiency (HP:0002850) | 1.77662943 |
| 74 | Menstrual irregularities (HP:0000858) | 1.73645406 |
| 75 | Pulmonary infiltrates (HP:0002113) | 1.72745613 |
| 76 | Fatigue (HP:0012378) | 1.72694225 |
| 77 | Lip pit (HP:0100267) | 1.72620795 |
| 78 | Recurrent bronchitis (HP:0002837) | 1.71838828 |
| 79 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.70583120 |
| 80 | Recurrent cutaneous fungal infections (HP:0011370) | 1.70583120 |
| 81 | Abnormality of the columella (HP:0009929) | 1.69929249 |
| 82 | Panhypogammaglobulinemia (HP:0003139) | 1.69786510 |
| 83 | Hypokalemia (HP:0002900) | 1.69676437 |
| 84 | Obstructive lung disease (HP:0006536) | 1.69633376 |
| 85 | Chronic obstructive pulmonary disease (HP:0006510) | 1.69633376 |
| 86 | Encephalitis (HP:0002383) | 1.69413134 |
| 87 | Peritonitis (HP:0002586) | 1.67008789 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 1.58938904 |
| 89 | Hemoptysis (HP:0002105) | 1.55772337 |
| 90 | Facial diplegia (HP:0001349) | 1.53564080 |
| 91 | Arterial thrombosis (HP:0004420) | 1.53197692 |
| 92 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.53053202 |
| 93 | Prostate neoplasm (HP:0100787) | 1.51999501 |
| 94 | Hypoalphalipoproteinemia (HP:0003233) | 1.49747300 |
| 95 | Hematochezia (HP:0002573) | 1.49280380 |
| 96 | Chronic otitis media (HP:0000389) | 1.49223528 |
| 97 | Neck muscle weakness (HP:0000467) | 1.48928009 |
| 98 | Glucose intolerance (HP:0000833) | 1.48695004 |
| 99 | 3-Methylglutaconic aciduria (HP:0003535) | 1.47650400 |
| 100 | Hypoplastic ischia (HP:0003175) | 1.46065771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.14221761 |
| 2 | TESK2 | 3.96693144 |
| 3 | OBSCN | 3.49088949 |
| 4 | JAK3 | 3.37253668 |
| 5 | PHKG1 | 3.00560863 |
| 6 | PHKG2 | 3.00560863 |
| 7 | RIPK4 | 2.30443028 |
| 8 | MAP4K1 | 2.24349624 |
| 9 | CAMKK2 | 2.13752058 |
| 10 | IRAK1 | 2.12192854 |
| 11 | PIK3CG | 2.07096476 |
| 12 | TEC | 1.88105090 |
| 13 | WNK4 | 1.82420359 |
| 14 | TNK2 | 1.82035237 |
| 15 | MAP2K3 | 1.80110972 |
| 16 | WNK1 | 1.77921596 |
| 17 | BLK | 1.69942826 |
| 18 | CAMK1D | 1.67242125 |
| 19 | FES | 1.53168761 |
| 20 | TXK | 1.50533537 |
| 21 | MST4 | 1.48934743 |
| 22 | CSK | 1.48530122 |
| 23 | TRPM7 | 1.45375582 |
| 24 | SYK | 1.40498765 |
| 25 | IKBKE | 1.38703026 |
| 26 | MAP3K14 | 1.36325699 |
| 27 | TYRO3 | 1.36035196 |
| 28 | TAOK3 | 1.32449549 |
| 29 | LIMK1 | 1.27771546 |
| 30 | GRK7 | 1.27256251 |
| 31 | TBK1 | 1.24934595 |
| 32 | CSF1R | 1.24396448 |
| 33 | TYK2 | 1.22808644 |
| 34 | MAPK13 | 1.20071387 |
| 35 | PIK3CA | 1.19008818 |
| 36 | MARK3 | 1.16748479 |
| 37 | BTK | 1.13210020 |
| 38 | CCNB1 | 1.08104190 |
| 39 | TESK1 | 1.07589039 |
| 40 | CDK4 | 1.06867653 |
| 41 | MAP3K11 | 1.02651749 |
| 42 | MAPK7 | 1.01962171 |
| 43 | MAP3K12 | 1.01118842 |
| 44 | DDR2 | 1.00616509 |
| 45 | MAP3K1 | 0.99419221 |
| 46 | FGFR3 | 0.98908714 |
| 47 | KIT | 0.97718204 |
| 48 | MAP3K3 | 0.95837626 |
| 49 | CAMK1G | 0.95724969 |
| 50 | DYRK1B | 0.95281974 |
| 51 | IRAK4 | 0.95262899 |
| 52 | TLK1 | 0.94408379 |
| 53 | ITK | 0.94286287 |
| 54 | FER | 0.90466661 |
| 55 | ERN1 | 0.84601819 |
| 56 | LYN | 0.83778464 |
| 57 | NUAK1 | 0.81157127 |
| 58 | CAMK2G | 0.78688673 |
| 59 | HCK | 0.76721313 |
| 60 | FRK | 0.76490519 |
| 61 | MAPK12 | 0.75057956 |
| 62 | EIF2AK3 | 0.74371486 |
| 63 | FGR | 0.71475285 |
| 64 | IKBKB | 0.69661675 |
| 65 | BMPR2 | 0.68776492 |
| 66 | LCK | 0.67955403 |
| 67 | TAOK1 | 0.67475474 |
| 68 | TGFBR2 | 0.67053168 |
| 69 | ZAP70 | 0.61883046 |
| 70 | PRKD2 | 0.60385694 |
| 71 | STK10 | 0.58014906 |
| 72 | OXSR1 | 0.56082615 |
| 73 | JAK1 | 0.55425925 |
| 74 | PIM1 | 0.55291549 |
| 75 | MOS | 0.54777204 |
| 76 | MAPKAPK3 | 0.53198368 |
| 77 | CHEK2 | 0.51711599 |
| 78 | PRKCQ | 0.49777036 |
| 79 | GRK6 | 0.49547148 |
| 80 | AURKA | 0.49389239 |
| 81 | PDK1 | 0.47488668 |
| 82 | JAK2 | 0.47443761 |
| 83 | NEK9 | 0.46748472 |
| 84 | SCYL2 | 0.46221279 |
| 85 | EIF2AK2 | 0.46013487 |
| 86 | BCKDK | 0.43838550 |
| 87 | PRKD1 | 0.42328941 |
| 88 | DAPK2 | 0.41594063 |
| 89 | SIK3 | 0.40424466 |
| 90 | CAMKK1 | 0.39720043 |
| 91 | TAOK2 | 0.38705986 |
| 92 | MATK | 0.38414368 |
| 93 | GRK1 | 0.38407400 |
| 94 | STK39 | 0.37276358 |
| 95 | NLK | 0.36523028 |
| 96 | PTK2B | 0.35611271 |
| 97 | NME2 | 0.35594850 |
| 98 | HIPK2 | 0.35471612 |
| 99 | ABL1 | 0.34988838 |
| 100 | MAPK11 | 0.32917190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.22231337 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.09849932 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.86654423 |
| 4 | Tight junction_Homo sapiens_hsa04530 | 2.73834095 |
| 5 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.72056796 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.65206053 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.47137924 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.29841494 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.29327485 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.24275552 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21639297 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.20062431 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.16266884 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.15615636 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 2.05968891 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01256852 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.89171584 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.77704020 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74224404 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.72112495 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63528757 |
| 22 | Platelet activation_Homo sapiens_hsa04611 | 1.54024818 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53023157 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50645315 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40881121 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39621199 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.39403389 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38917599 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37769764 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34744400 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33103537 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22803030 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.21096045 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.20083629 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19324556 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.14502555 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.14309275 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.14056856 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12869312 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.06671391 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.01886378 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00676661 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96231366 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92307357 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91846865 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91444818 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90244531 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.88503543 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88121512 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87224433 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83864074 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83314758 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82471860 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.82265889 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74965367 |
| 56 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.74550704 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.73336199 |
| 58 | Endocytosis_Homo sapiens_hsa04144 | 0.67860210 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66878249 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66272452 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65855110 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65599827 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.64803824 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.64010159 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63345178 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61517317 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60110365 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55632390 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53197343 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52249029 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51712923 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50937115 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48487264 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.47642993 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46625719 |
| 76 | Proteasome_Homo sapiens_hsa03050 | 0.46089802 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45665695 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43620996 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.43528170 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.42947398 |
| 81 | Long-term depression_Homo sapiens_hsa04730 | 0.42035744 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41851291 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41114436 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40481863 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40097540 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39815443 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39669019 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37491157 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37007271 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.36509880 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36221398 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34033012 |
| 93 | Adherens junction_Homo sapiens_hsa04520 | 0.32220841 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31073437 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30639696 |
| 96 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.29872617 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28432095 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25733940 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.25122655 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.24343921 |

